Literature DB >> 923180

Propranolol serum levels during twenty-four hours.

E Vervloet, B F Pluym, J Cilissen, K Köhlen, F W Merkus.   

Abstract

Propranolol serum levels during a 24-hr period were determined every 2 hr in 9 hospitalized patients with angina pectoris after oral administration of 40 mg of propranolol 3 times a day. After the first, second, and third tablets the mean maximum serum propranolol concentrations averaged 118 +/- 71 ng/ml, 134 +/- 97 ng/ml, and 118 +/- 94 ng/ml and the mean minimum concentrations averaged 21 +/- 18 ng/ml, 45 +/- 25 ng/ml, and 54 +/- 34 ng/ml (+/-SD), respectively. These data show a very wide inter- and intraindividual variation in serum propranolol levels. No relationship was found between serum level and blood pressure or dose (related to body weight).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923180     DOI: 10.1002/cpt1977226853

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Bioavailability of propranolol after oral, sublingual, and intranasal administration.

Authors:  G S Duchateau; J Zuidema; F W Merkus
Journal:  Pharm Res       Date:  1986-04       Impact factor: 4.200

2.  Avoidance of first-pass metabolism of propranolol after rectal administration as a function of the absorption site.

Authors:  K Iwamoto; J Watanabe
Journal:  Pharm Res       Date:  1985-01       Impact factor: 4.200

3.  The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats.

Authors:  T Berkan; L Ustünes; Z Kerry; M Karol; M Tosun; C Yalçinkaya; A Ozer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

4.  Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.

Authors:  H Halkin; I Vered; A Saginer; B Rabinowitz
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

5.  Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.

Authors:  G L Sanders; D M Davies; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Relationship between plasma propranolol concentration and relief of essential tremor.

Authors:  D Jefferson; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154

8.  Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

9.  Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients.

Authors:  W A Wargin; R J Sawchuk; J W McBride; H G McCoy; M L Rylander
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

10.  Right ventricular performance in essential hypertension after beta-blockade.

Authors:  J Ferlinz; J L Easthope; D Hughes; J Siegel; J Tobis; W S Aronow
Journal:  Br Heart J       Date:  1981-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.